{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T13:16:57Z","timestamp":1788268617995,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T00:00:00Z","timestamp":1720051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bcp.2024.116411","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T06:49:47Z","timestamp":1720162187000},"page":"116411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["miR-218-5p promotes hepatic lipogenesis through targeting Elovl5 in non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"226","author":[{"given":"Guanlin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianhong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-5471","authenticated-orcid":false,"given":"Lina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bcp.2024.116411_b0005","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2024.116411_b0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cld.2017.08.003","article-title":"The natural history of nonalcoholic fatty liver disease-an evolving view","volume":"22","author":"Lindenmeyer","year":"2018","journal-title":"Clin. Liver Dis."},{"issue":"7","key":"10.1016\/j.bcp.2024.116411_b0015","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116411_b0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1439-0396.2007.00752.x","article-title":"Liver lipid metabolism","volume":"92","author":"Nguyen","year":"2008","journal-title":"J. Anim. Physiol. Anim. Nutr."},{"issue":"2","key":"10.1016\/j.bcp.2024.116411_b0025","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"issue":"46","key":"10.1016\/j.bcp.2024.116411_b0030","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1038\/sj.onc.1209909","article-title":"Principles and effects of microRNA-mediated post-transcriptional gene regulation","volume":"25","author":"Engels","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2024.116411_b0035","doi-asserted-by":"crossref","unstructured":"M. Hill, N. Tran, miRNA interplay: mechanisms and consequences in cancer, Dis. Model Mech. 14 (4) (2021) dmm047662. https:\/\/doi.org\/10.1242\/dmm.047662.","DOI":"10.1242\/dmm.047662"},{"issue":"11","key":"10.1016\/j.bcp.2024.116411_b0040","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","article-title":"Stress-activated miR-21\/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with HFD consumption","volume":"65","author":"Calo","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2024.116411_b0045","doi-asserted-by":"crossref","unstructured":"J.K. Long, W. Dai, Y.W. Zheng, S.P. Zhao, miR-122 promotes hepatic lipogenesis via inhibiting the LKB1\/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease, Mol. Med. 25 (1) (2019) 26. https:\/\/doi.org\/ 10.1186\/s10020-019-0085-2.","DOI":"10.1186\/s10020-019-0085-2"},{"key":"10.1016\/j.bcp.2024.116411_b0050","doi-asserted-by":"crossref","unstructured":"K. Jampoka, P. Muangpaisarn, K. Khongnomnan, S. Treeprasertsuk, P. Tangkijvanich, S. Payungporn, Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD). Microrna 7 (3) (2018) 215-222. https:\/\/doi.org\/10.2174\/2211536607666180531093302.","DOI":"10.2174\/2211536607666180531093302"},{"issue":"10","key":"10.1016\/j.bcp.2024.116411_b0055","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1016\/j.apsb.2021.03.022","article-title":"3D disorganization and rearrangement of genome provide insights into pathogenesis of NAFLD by integrated Hi-C, Nanopore, and RNA sequencing","volume":"11","author":"Xu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"10","key":"10.1016\/j.bcp.2024.116411_b0060","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/jat.4144","article-title":"Plasma miR-218a-5p as a biomarker for acute cholestatic liver injury in rats and investigation of its pathophysiological roles","volume":"41","author":"Oda","year":"2021","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bcp.2024.116411_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/mmr.2021.12517","article-title":"Role of microRNA-218-5p in sevoflurane-induced protective effects in hepatic ischemia\/reperfusion injury mice by regulating GAB2\/PI3K\/AKT pathway","volume":"25","author":"Ji","year":"2022","journal-title":"Mol. Med. Rep."},{"issue":"13","key":"10.1016\/j.bcp.2024.116411_b0070","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1042\/CS20190394","article-title":"CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p\/TXNDC5 signaling pathway","volume":"133","author":"Yu","year":"2019","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bcp.2024.116411_b0075","doi-asserted-by":"crossref","unstructured":"Y. Wang, M. Torres-Gonzalez, S. Tripathy, D. Botolin, B. Christian, D.B. Jump, Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition, J. Lipid Res. 49 (7) (2008) 1538-1552. https:\/\/doi.org\/ 10.1194\/jlr.M800123-JLR200.","DOI":"10.1194\/jlr.M800123-JLR200"},{"issue":"9","key":"10.1016\/j.bcp.2024.116411_b0080","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1194\/jlr.M006080","article-title":"Elevated hepatic fatty acid elongase-5 activity corrects dietary fat-induced hyperglycemia in obese C57BL\/6J mice","volume":"51","author":"Tripathy","year":"2010","journal-title":"J. Lipid Res."},{"issue":"4","key":"10.1016\/j.bcp.2024.116411_b0085","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.bbrc.2020.08.102","article-title":"Adrenic acid induces oxidative stress in hepatocytes","volume":"532","author":"Zhao","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2024.116411_b0090","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.freeradbiomed.2019.06.019","article-title":"Berberine attenuates nonalcoholic hepatic steatosis through the AMPK-SREBP-1c-SCD1 pathway","volume":"141","author":"Zhu","year":"2019","journal-title":"Free Radic Biol Med."},{"issue":"3","key":"10.1016\/j.bcp.2024.116411_b0095","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1194\/jlr.M800383-JLR200","article-title":"Deletion of ELOVL5 leads to fatty liver through activation of SREBP-1c in mice","volume":"50","author":"Moon","year":"2009","journal-title":"J. Lipid Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116411_b0100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/ijms20020298","article-title":"Homeostasis of glucose and lipid in non-alcoholic fatty liver disease","volume":"20","author":"Chao","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2024.116411_b0105","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s12072-023-10513-0","article-title":"Liver-derived extracellular vesicles from patients with hepatitis B virus-related acute-on-chronic liver failure impair hepatic regeneration by inhibiting on FGFR2 signaling via miR-218-5p","volume":"13","author":"Zhang","year":"2023","journal-title":"Hepatol. Int."},{"issue":"5","key":"10.1016\/j.bcp.2024.116411_b0110","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1093\/bib\/bby054","article-title":"Trends in the development of miRNA bioinformatics tools","volume":"20","author":"Chen","year":"2019","journal-title":"Brief. Bioinform."},{"issue":"7","key":"10.1016\/j.bcp.2024.116411_b0115","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/ijms18071405","article-title":"Estrogen promotes hepatic synthesis of long-chain polyunsaturated fatty acids by regulating ELOVL5 at post-transcriptional level in laying hens","volume":"18","author":"Zhang","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2024.116411_b0120","doi-asserted-by":"crossref","first-page":"e151895","DOI":"10.1172\/JCI151895","article-title":"Inhibiting SCAP\/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis","volume":"132","author":"Kawamura","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"11","key":"10.1016\/j.bcp.2024.116411_b0125","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: from pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224003940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224003940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T00:12:37Z","timestamp":1728346357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224003940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":25,"alternative-id":["S0006295224003940"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116411","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"miR-218-5p promotes hepatic lipogenesis through targeting Elovl5 in non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116411","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116411"}}